Text of HI SR 126 (2021)
Requesting The Auditor To Assess The Social And Financial Effects Of Requiring Health Insurers To Provide Coverage For Health Care Services Related To Gender Transition Treatments.
Legislative text is a public record. Where LegiScan supplied it, the CC BY 4.0 credit applies.
Source: LegiScan. Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative. License: CC BY 4.0(opens another site). Source page(opens another site)
As introduced
6,927 characters
THE SENATE
S.R. NO.
126
THIRTY-FIRST LEGISLATURE, 2021
STATE OF HAWAII
SENATE RESOLUTION
supporting and urging the inclusion of gender transition treatments
and services as medically necessary for the purposes of health care insurance coverage.
WHEREAS, according
to the American Medical Association, approximately 1,400,000 adults and 150,000
youth ages thirteen to seventeen in the United States identify as transgender, meaning
those individuals' gender identity and/or expression is different from cultural
expectations based on the sex they were assigned at birth, or identify as gender
expansive, meaning they identify with neither a traditional binary gender role nor
a single gender narrative or experience; and
WHEREAS, many
but not all transgender people experience gender dysphoria, a medical condition
defined by the American Medical Association as a "conflict between a person's
physical or assigned gender and the gender with which he/she/they identify";
and
WHEREAS, standards
of care and accepted medically necessary services that affirm gender or treat gender
dysphoria may include but are not limited to mental health counseling, non-medical
social transition, gender-affirming hormone therapy, and gender-affirming surgeries;
and
WHEREAS, every
major medical association in the United States recognizes the medical necessity
of transition-related care for improving the physical and mental health of transgender
people and has called for health insurance coverage for treatment of gender dysphoria;
and
WHEREAS, as a
population, transgender individuals are frequently subject to bias and discrimination
in many aspects of their lives, including the provision of health care; and
WHEREAS, the transgender population is less
likely to be insured than the lesbian, gay, and bisexual (LGB) and general populations
and often faces challenges in accessing needed health care services; and
WHEREAS, a 2016
report by the National Center for Transgender Equality found that:
(1) Twenty-five percent of surveyed respondents experienced
a problem with their insurance in the past year related to being transgender, such
as being denied coverage for care related to gender transition;
(2) Twenty-five percent of those who sought coverage
for hormones in the past year were denied;
(3) Fifty-five percent of those who sought coverage
for transition-related surgery in the past year were denied;
(4) Seventy-eight percent of respondents wanted hormone
therapy related to gender transition, but only forty-nine percent had ever received
it;
(5) Forty-two percent reported that insurance covered
only some of the surgical care needed for transition; and
(6) Twenty-one percent reported that insurance covered
transition-related surgery, but had no in-network providers; and
WHEREAS, according
to the American Medical Association, transgender individuals in the United States
are three times more likely than the general population to report or be diagnosed
with mental health disorders, with as many as 41.5 percent reporting at least one
diagnosis of a mental health or substance abuse disorder; and
WHEREAS, the increased
prevalence of these mental health conditions is widely thought to be a consequence
of minority stress, which is the chronic stress from coping with societal stigma
and discrimination because of one's gender identity and expression; and
WHEREAS, gender-based
discrimination affecting access to services is a strong predictor of suicide risk
among transgender persons; and
WHEREAS, lack
of access to gender-affirming care may directly contribute to poor mental health,
and individuals with gender dysphoria who have undergone no gender confirmation
treatment are twice as likely to experience moderate to severe depression and four
times more likely to experience anxiety than their surgically-affirmed peers;
and
WHEREAS, improving
access to gender-affirming care is an important means of improving health outcomes
for the transgender population; and
WHEREAS, patients
who receive gender-affirming care, including surgical care, feel more congruent
in their bodies and report improved mental health; and
WHEREAS, studies
suggest that improved body satisfaction and self-esteem following medical and surgical
therapies is protective against poorer mental health and also supports healthy relationships
with parents and peers; and
WHEREAS, positive
health effects from gender-affirming care extend to children and adolescents as
well, and recent research demonstrates that integrated affirmative models of care
for youths, which include access to medications and surgeries, result in fewer mental
health concerns than have been historically seen among transgender populations;
and
WHEREAS, this body opposes the
denial of health insurance coverage for certain types of health care treatments
and services on the basis of gender identity; provided that a health insurance
policy, contract, plan, or agreement covers those treatments and services for
purposes other than gender transition; now, therefore,
BE IT RESOLVED by the Senate of the Thirty-first
Legislature of the State of Hawaii, Regular Session of 2021, that this body supports
and urges the inclusion of gender transition treatments and services as medically
necessary for the purposes of health care insurance coverage; and
BE IT FURTHER
RESOLVED that the inclusion of such gender transition treatments and services as
medically necessary for the purposes of health care insurance coverage is urged
to include but not be limited to:
(1) Hormone therapies;
(2) Hysterectomies;
(3) Mastectomies;
(4) Vocal training;
(5) Feminizing vaginoplasties;
(6) Masculinizing phalloplasties;
(7) Metaoidioplasties;
(8) Breast augmentation;
(9) Masculinizing chest surgeries;
(10) Facial feminization surgeries;
(11) Reduction thyroid chondroplasties;
(12) Voice surgeries;
(13) Laser hair removal; and
(14) Smoking cessation therapies; and
BE IT FURTHER
RESOLVED that certified copies of this Resolution be transmitted to the Governor,
Lieutenant Governor, Director of Health, Director of Commerce and Consumer Affairs,
and Insurance Commissioner.
OFFERED BY:
_____________________________
Report Title:
Gender
Transition Services; Health Care Insurance Coverage